Serendipity: decitabine monotherapy induced complete molecular response in a 77-year-old patient with acute promyelocytic leukemia

• Ramzi Abboud,
• Se Young Han,
• Eric J. Duncavage,
• Amanda F. Cashen,
• Cara Lunn Shirai,
• John S. Welch,
• John F. DiPersio,
• Camille N. Abboud

Affiliations

Ramzi Abboud

BMT and Leukemia Program, Department of Medicine, Washington University School of Medicine, Saint Louis, MO

Se Young Han

Hematology, Oncology, and Transplantation Division, Department of Medicine, University of Minneapolis, MN, USA

Eric J. Duncavage

BMT and Leukemia Program, Department of Medicine, Washington University School of Medicine, Saint Louis, MO

Amanda F. Cashen

BMT and Leukemia Program, Department of Medicine, Washington University School of Medicine, Saint Louis, MO

Cara Lunn Shirai

BMT and Leukemia Program, Department of Medicine, Washington University School of Medicine, Saint Louis, MO

John S. Welch

BMT and Leukemia Program, Department of Medicine, Washington University School of Medicine, Saint Louis, MO

John F. DiPersio

BMT and Leukemia Program, Department of Medicine, Washington University School of Medicine, Saint Louis, MO

Camille N. Abboud

BMT and Leukemia Program, Department of Medicine, Washington University School of Medicine, Saint Louis, MO